Johnson RL., Kopp SL., Burkle CM., Duncan CM., Jacob AK., Erwin PJ, et al. 2016. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: a systematic review of comparative-effectiveness research. Br J Anaesth. 116:163–76. DOI:
10.1093/bja/aev455. PMID:
26787787.
Rawal N., Van Zundert A A., Holmström B., Crowhurst JA. 1997. Combined spinal-epidural technique. Reg Anesth. 22:406–23. DOI:
10.1016/S1098-7339(97)80026-0.
Höhener D., Blumenthal S., Borgeat A. 2008. Sedation and regional anaesthesia in the adult patient. Br J Anaesth. 100:8–16. DOI:
10.1093/bja/aem342. PMID:
18070783.
Virtanen R., Savola JM., Saano V., Nyman L. 1988. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 150:9–14. DOI:
10.1016/0014-2999(88)90744-3. PMID:
2900154.
Lee MJ., Koo DJ., Choi YS., Lee KC., Kim HY. 2016. Dexamethasone or dexmedetomidine as local anesthetic adjuvants for ultrasound-guided axillary brachial plexus blocks with nerve stimulation. Korean J Pain. 29:29–33. DOI:
10.3344/kjp.2016.29.1.29. PMID:
26839668. PMCID:
PMC4731548.
Dawson C., Ma D., Chow A., Maze M. 2004. Dexmedetomidine enhances analgesic action of nitrous oxide: mechanisms of action. Anesthesiology. 100:894–904. DOI:
10.1097/00000542-200404000-00020. PMID:
15087625.
Elcicek K., Tekin M., Kati I. 2010. The effects of intravenous dexmedetomidine on spinal hyperbaric ropivacaine anesthesia. J Anesth. 24:544–8. DOI:
10.1007/s00540-010-0939-9. PMID:
20467879.
Hussain N., Grzywacz VP., Ferreri CA., Atrey A., Banfield L., Shaparin N, et al. 2017. Investigating the efficacy of dexmedetomidine as an adjuvant to local anesthesia in brachial plexus block: a systematic review and meta-analysis of 18 randomized controlled trials. Reg Anesth Pain Med. 42:184–96. DOI:
10.1097/AAP.0000000000000564. PMID:
28178091.
Zhang X., Wang D., Shi M., Luo Y. 2017. Efficacy and safety of dexmedetomidine as an adjuvant in epidural analgesia and anesthesia: a systematic review and meta-analysis of randomized controlled trials. Clin Drug Investig. 37:343–54. DOI:
10.1007/s40261-016-0477-9. PMID:
27812971.
Al-Mustafa MM., Badran IZ., Abu-Ali HM., Al-Barazangi BA., Massad IM., Al-Ghanem SM. 2009. Intravenous dexmedetomidine prolongs bupivacaine spinal analgesia. Middle East J Anaesthesiol. 20:225–31. PMID:
19583070.
Hong JY., Kim WO., Yoon Y., Choi Y., Kim SH., Kil HK. 2012. Effects of intravenous dexmedetomidine on low-dose bupivacaine spinal anaesthesia in elderly patients. Acta Anaesthesiol Scand. 56:382–7. DOI:
10.1111/j.1399-6576.2011.02614.x. PMID:
22220945.
Kaya FN., Yavascaoglu B., Turker G., Yildirim A., Gurbet A., Mogol EB, et al. 2010. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth. 57:39–45. DOI:
10.1007/s12630-009-9231-6. PMID:
20039221.
Jorm CM., Stamford JA. 1993. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. Br J Anaesth. 71:447–9. DOI:
10.1093/bja/71.3.447. PMID:
8104450.
Dinesh CN., Sai Tej NA NA., Yatish B., Pujari VS., Mohan Kumar RM RM., Mohan CV. 2014. Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: a randomized study. Saudi J Anaesth. 8:202–8. DOI:
10.4103/1658-354X.130719. PMID:
24843333. PMCID:
PMC4024677.
Li A., Yuen VM., Goulay-Dufay S., Kwok PC. 2016. Pharmacokinetics and pharmacodynamics of dexmedetomidine. Drug Dev Ind Pharm. 42:1917–1927. DOI:
10.1080/03639045.2016.1232727. PMID:
27595299.
Ganesh M., Krishnamurthy D. 2018. A comparative study of dexmedetomidine and clonidine as an adjuvant to intrathecal bupivacaine in lower abdominal surgeries. Anesth Essays Res. 12:539–45. DOI:
10.4103/aer.AER_54_18. PMID:
29962631. PMCID:
PMC6020565.
Abdallah FW., Abrishami A., Brull R. 2013. The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia: a systematic review and meta-analysis. Anesth Analg. 117:271–8. DOI:
10.1213/ANE.0b013e318290c566. PMID:
23632057.
Arain SR., Ebert TJ. 2002. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 95:461–6. DOI:
10.1213/00000539-200208000-00042. PMID:
12145072.
Cortinez LI., Hsu YW., Sum-Ping ST., Young C., Keifer JC., Macleod D, et al. 2004. Dexmedetomidine pharmacodynamics: part II: crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 101:1077–83. DOI:
10.1097/00000542-200411000-00006. PMID:
15505442.
Alhashemi JA. 2006. Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery. Br J Anaesth. 96:722–6. DOI:
10.1093/bja/ael080. PMID:
16595611.